# Ultra-Low-Flow Anesthesia and Carbon Footprint

> **NCT07313969** · NA · COMPLETED · sponsor: **Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital** · enrollment: 92 (actual)

## Conditions studied

- Low Flow Anesthesia
- Sevoflurane Anesthesia
- Cardiac Surgery

## Interventions

- **DRUG:** ultra low flow anesthesia
- **DRUG:** normal flow anesthesia

## Key facts

- **NCT ID:** NCT07313969
- **Lead sponsor:** Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-30
- **Primary completion:** 2025-09-15
- **Final completion:** 2026-01-15
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313969, "Ultra-Low-Flow Anesthesia and Carbon Footprint". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07313969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*